HIV Infections
Showing NaN - NaN of 357
HIV, Cognitive Impairment Trial in Birmingham, Aurora, Seattle (Phase 1 Gym Exercise HIIT, Phase 1 Gym Exercise CME, Phase 2
Not yet recruiting
- HIV Infections
- Cognitive Impairment
- Phase 1 Gym Exercise HIIT
- +3 more
-
Birmingham, Alabama
- +2 more
Aug 22, 2023
Implementation and Delivery of Cabotegravir Long Acting
Not yet recruiting
- HIV Infections
- Cabotegravir Injection [Apretude]
-
Seattle, Washington
- +1 more
May 16, 2023
HIV Trial in Worldwide (Oral Cabotegravir (CAB), Oral Rilpivirine (RPV), Long-Acting Injectable Cabotegravir (CAB LA))
Recruiting
- HIV Infections
- Oral Cabotegravir (CAB)
- +4 more
-
La Jolla, California
- +30 more
Feb 2, 2023
HIV Trial in United States (BG505 MD39.3 mRNA, BG505 MD39.3 gp151 mRNA, BG505 MD39.3 gp151 CD4KO mRNA)
Suspended
- HIV Infections
- BG505 MD39.3 mRNA
- +2 more
-
Birmingham, Alabama
- +9 more
Feb 1, 2023
Hepatitis B, HIV Trial in Worldwide (Selgantolimod, Placebo)
Recruiting
- Hepatitis B
- HIV Infections
- Selgantolimod
- Placebo
-
San Diego, California
- +35 more
Jan 31, 2023
HIV Trial in Worldwide (Cabotegravir Tablets, Cabotegravir Injectable Suspension (CAB LA), Rilpivirine Tablets)
Active, not recruiting
- HIV Infections
- Cabotegravir Tablets
- +4 more
-
Bakersfield, California
- +116 more
Jan 22, 2023
Consent for Use of Stored Patient Specimens for Future Testing
Recruiting
- HIV Infections
-
Los Angeles, California
- +62 more
Dec 7, 2022
Lipodystrophy, HIV Trial in Worldwide (Tesamorelin, Placebo for Tesamorelin)
Completed
- Lipodystrophy
- HIV Infections
- Tesamorelin
- Placebo for Tesamorelin
-
Birmingham, Alabama
- +46 more
Sep 16, 2022
Antiretroviral Drugs and Related Drugs During and After
HIV Trial in United States (MPER-656 Liposome Vaccine, Placebo for MPER-656 Liposome Vaccine)
Completed
- HIV Infections
- MPER-656 Liposome Vaccine
- Placebo for MPER-656 Liposome Vaccine
-
Birmingham, Alabama
- +5 more
Jun 15, 2022
Cytomegalovirus Infections, HIV, Vaccine Trial in United States (CMV-MVA Triplex, Placebo)
Recruiting
- Cytomegalovirus Infections
- +2 more
- CMV-MVA Triplex
- Placebo
-
Birmingham, Alabama
- +11 more
Jun 20, 2022
HIV, Cytomegalovirus, CMV Trial in United States (Letermovir 240 MG Oral Tablet, Letermovir 480 MG Oral Tablet, Combination ART)
Recruiting
- HIV Infections
- +2 more
- Letermovir 240 MG Oral Tablet
- +2 more
-
Birmingham, Alabama
- +18 more
Jun 20, 2022
HIV Trial in Boston, Seattle, Nairobi (BG505 SOSIP.664 gp140, adjuvanted, Placebo)
Active, not recruiting
- HIV Infections
- BG505 SOSIP.664 gp140, adjuvanted
- Placebo
-
Boston, Massachusetts
- +2 more
May 6, 2022
HIV Trial in Worldwide (Placebo for maraviroc (MVC), Placebo for dolutegravir (DTG), Dolutegravir (DTG))
Completed
- HIV Infections
- Placebo for maraviroc (MVC)
- +3 more
-
Los Angeles, California
- +29 more
Apr 20, 2022
HIV, Smoking, Smoking Cessation Trial in Seattle (Wellness Intervention for Smokers with HIV)
Recruiting
- HIV Infections
- +2 more
- Wellness Intervention for Smokers with HIV
-
Seattle, WashingtonVA Puget Sound Health Care System Seattle Division
Mar 15, 2022
Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK1349572, Raltegravir, GSK1349572 Placebo)
Completed
- Infection, Human Immunodeficiency Virus
- HIV Infections
- GSK1349572
- +3 more
-
Birmingham, Alabama
- +180 more
Mar 14, 2022
HIV Trial in United States (Doravirine 100 Mg, Tenofovir alafenamide/emtricitabine, tenofovir alafenamide/lamivudine)
Recruiting
- HIV Infections
- Doravirine 100 Mg
- +5 more
-
Birmingham, Alabama
- +22 more
Feb 22, 2022
HIV Trial in Worldwide (VRC01, Placebo for VRC01)
Completed
- HIV Infections
- VRC01
- Placebo for VRC01
-
Birmingham, Alabama
- +25 more
Feb 8, 2022
HIV, Non-Alcoholic Fatty Liver Disease Trial in Brazil, United States (Semaglutide)
Recruiting
- HIV Infections
- Non-Alcoholic Fatty Liver Disease
-
Birmingham, Alabama
- +8 more
Jan 28, 2022
HIV Trial in Worldwide (DTG 50 mg, RPV 25 mg, CAR)
Active, not recruiting
- HIV Infections
- DTG 50 mg
- +2 more
-
Bakersfield, California
- +61 more
Dec 3, 2021
HIV Trial in Puerto Rico, United States (Standard of Care (SOC) Oral ART, Oral RPV, Oral CAB)
Recruiting
- HIV Infections
- Standard of Care (SOC) Oral ART
- +6 more
-
Birmingham, Alabama
- +34 more
Dec 1, 2021